WHO ICTRP trial
The efficacy and safety research of sacubitril/valsartan in HF with preserved…
ChiCTR2400092130 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400092130 |
|---|---|
| Public title | The efficacy and safety research of sacubitril/valsartan in HF with preserved ejection fraction in patients on maintenance dialysis |
| Scientific title | The efficacy and safety research of sacubitril/valsartan in HF with preserved ejection fraction in patients on maintenance dialysis |
| Primary sponsor | Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | heart failure with preserved ejection fraction (HFpEF) in patients on maintenance dialysis |
| Interventions | Group A:standard HF treatments+sacubitril-valsartan;Group B:standard HF treatments+valsartan |
| Registration date | Nov 11, 2024 |
| Target size | Group A:15;Group B:15 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: